Portfolio
LHi Technology Private Limited
| Investment type | Buyouts |
|---|---|
| Region | South East Asia |
| Status | Current investment |
Nature of Business
LHi Technology is a leading medical cables manufacturer, focused on the production of Patient Monitoring and Surgical cable interconnects and assemblies. It is a major supplier to the growing global medical assemblies market and is the only Asia-based supplier to develop, manufacture and sell medical cable assemblies exclusively to medical device companies and OEMs internationally.
Founded by a Singaporean entrepreneur, LHi operates from a high-quality manufacturing base in Shenzhen, China. The company also has offices in Hong Kong, the US, Europe and Japan.
Investment Overview
We completed a secondary buyout of LHi Technology in April 2008 in a €72m deal. Founder and CEO, Jay Pok had already carved out a profitable and prominent niche in the growing medical assemblies market and we recognised a clear opportunity to align this potential with our experience in the healthcare sector and leverage our Asian network.
Working in partnership with the management team, we have implemented several strategies during the last 12 months to drive growth, improve top-line performance and optimise key costs such as freight and distribution.
LHi’s key strength is its low-cost, highly-efficient manufacturing facility in China which allows the company to maintain stable pricing and robust margins. Its in-house design team and flexibility in production means that it is very focused on new product development. In parallel with its customers, LHi is evolving from an outsourcing model to being intimately engaged with new product design and development.
Using our Asian network, we have introduced 3i Healthcare sector partner Al Bautista as Chairman. He is working closely with the CEO on important operational initiatives, including sales force effectiveness and marketing strategy. In particular he is focusing on developing the US sales force in alignment with new product development to target new sectors.
